LeadIQ logo
Learn more at LeadIQ.com

Insights

Lead Programme in Cancer Treatment Epsilogen is pioneering the development of IgE antibodies for cancer treatment, with a phase I trial targeting ovarian cancer. This innovative approach presents a unique selling point in the oncology therapeutics market.

Clinical Trial Milestone Being the first company to introduce an IgE therapeutic into clinical trials positions Epsilogen as a frontrunner in biotechnology research. This achievement can be leveraged to attract partnerships and investments.

Specialized Immunotherapy Focus The specialization in IgE antibodies for solid tumor treatment showcases Epsilogen's commitment to cutting-edge immunotherapy solutions. This focus can appeal to clinics and institutions seeking advanced cancer therapies.

Financial Stability with Funding Despite being a relatively small company, Epsilogen's $16M funding demonstrates financial stability and growth potential. This financial backing can instill confidence in potential clients and investors.

Opportunity for Strategic Alliances By identifying similar companies like epiGenesys and Genetix in the industry, Epsilogen can explore collaboration opportunities, joint ventures, or acquisition targets to strengthen market positioning and expand its reach.

Similar companies to Epsilogen Ltd

Epsilogen Ltd Tech Stack

Epsilogen Ltd uses 8 technology products and services including WordPress, MySQL, Shopify, and more. Explore Epsilogen Ltd's tech stack below.

  • WordPress
    Content Management System
  • MySQL
    Database
  • Shopify
    E-commerce
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Modernizr
    Javascript Libraries
  • Cloudways
    Platform As A Service
  • PHP
    Programming Languages
  • Nginx
    Web Servers

Media & News

Epsilogen Ltd's Email Address Formats

Epsilogen Ltd uses at least 1 format(s):
Epsilogen Ltd Email FormatsExamplePercentage
First@epsilogen.comJohn@epsilogen.com
46%
Middle@epsilogen.comMichael@epsilogen.com
4%
First@epsilogen.comJohn@epsilogen.com
46%
Middle@epsilogen.comMichael@epsilogen.com
4%

Frequently Asked Questions

Where is Epsilogen Ltd's headquarters located?

Minus sign iconPlus sign icon
Epsilogen Ltd's main headquarters is located at Waterfront ARC West London, Manbre Road Hammersmith, W6 9RH GB. The company has employees across 1 continents, including Europe.

What is Epsilogen Ltd's official website and social media links?

Minus sign iconPlus sign icon
Epsilogen Ltd's official website is epsilogen.com and has social profiles on LinkedIn.

How much revenue does Epsilogen Ltd generate?

Minus sign iconPlus sign icon
As of October 2024, Epsilogen Ltd's annual revenue reached $1.8M.

What is Epsilogen Ltd's SIC code NAICS code?

Minus sign iconPlus sign icon
Epsilogen Ltd's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Epsilogen Ltd have currently?

Minus sign iconPlus sign icon
As of October 2024, Epsilogen Ltd has approximately 29 employees across 1 continents, including Europe. Key team members include Chief Business Officer: A. N.Chief Scientific Officer: K. F.Chief Financial Officer: N. R.. Explore Epsilogen Ltd's employee directory with LeadIQ.

What industry does Epsilogen Ltd belong to?

Minus sign iconPlus sign icon
Epsilogen Ltd operates in the Biotechnology Research industry.

What technology does Epsilogen Ltd use?

Minus sign iconPlus sign icon
Epsilogen Ltd's tech stack includes WordPressMySQLShopifyTwitter Emoji (Twemoji)ModernizrCloudwaysPHPNginx.

What is Epsilogen Ltd's email format?

Minus sign iconPlus sign icon
Epsilogen Ltd's email format typically follows the pattern of . Find more Epsilogen Ltd email formats with LeadIQ.

How much funding has Epsilogen Ltd raised to date?

Minus sign iconPlus sign icon
As of October 2024, Epsilogen Ltd has raised $16M in funding. The last funding round occurred on Sep 09, 2024 for $16M.

When was Epsilogen Ltd founded?

Minus sign iconPlus sign icon
Epsilogen Ltd was founded in 2016.
Epsilogen Ltd

Epsilogen Ltd

Biotechnology ResearchHammersmith, United Kingdom11-50 Employees

Epsilogen is a global leader in the development of immunoglobulin (IgE) antibodies to treat cancer.  IgE has several key features that make it ideal for the treatment of solid tumours including greater potency, enhanced tumour access and a long tissue half-life.

The company's lead programme targets the folate receptor alpha (FR alpha) and an anti-FR alpha IgE antibody is currently in a phase I trial to treat ovarian cancer.  This is the world's first IgE therapeutic to enter the clinic.

Section iconCompany Overview

Headquarters
Waterfront ARC West London, Manbre Road Hammersmith, W6 9RH GB
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $16M

    Epsilogen Ltd has raised a total of $16M of funding over 6 rounds. Their latest funding round was raised on Sep 09, 2024 in the amount of $16M.

  • $10M

    Epsilogen Ltd's revenue is in the range of $10M

Section iconFunding & Financials

  • $16M

    Epsilogen Ltd has raised a total of $16M of funding over 6 rounds. Their latest funding round was raised on Sep 09, 2024 in the amount of $16M.

  • $10M

    Epsilogen Ltd's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.